Completed NA INTERVENTIONAL 2-arm NCT06376838

To Prove the Non-inferiority of DLMR01 by Evaluating the Injecting Efficacy and Safety DLMR01 and Control for Patients in Crow's Feet (dermal filler)

A Randomized, Subject and Evaluator Blinded, Split-face, Pivotal, Multi-injection Clinical Trial to Evaluate the Efficacy and Safety of DLMR01 in Crow's Feet.

Sponsor: DEXLEVO

Conditions Crow's Feet Lines

Interventions DLMR01 Rejuran

Updated 4 times since 2024 Last updated: Apr 17, 2024 Started: Jul 7, 2020 Primary completion: Oct 15, 2021 Completion: May 4, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06376838, this NA trial focuses on Crow's Feet Lines and remains completed. Sponsored by DEXLEVO, it has been updated 4 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
May 2024 — Jul 2024 [monthly]

Completed NA

First recorded

Jul 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

DEXLEVO

Data source: DEXLEVO

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea